ISSN 0975-3583
 

Journal of Cardiovascular Disease Research



    Role Of Ramosetron 5-HT3 Receptor Antagonists In The Treatment Of Irritable Bowel Syndrome (Diarrhea Dominant)


    Dr. Ashish Ranjan, Dr. Deepak Kumar, Dr. Chaman Jee
    JCDR. 2020: 118-123

    Abstract

    Background: One of the most common functional gastrointestinal illnesses, irritable bowel syndrome (IBS), significantly impairs quality of life. The present study was conducted to assess the role of the 5-HT3 receptor antagonist Ramosetron in the treatment of irritable bowel syndrome.

    Description

    .

    » PDF

    Volume & Issue

    Volume 11 Issue 11

    Keywords